nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—osteoarthritis—Prednisone—systemic scleroderma	0.401	1	CpDpCtD
Flurbiprofen—UGT1A9—Mycophenolic acid—systemic scleroderma	0.0794	0.179	CbGbCtD
Flurbiprofen—UGT2B7—Mycophenolic acid—systemic scleroderma	0.0752	0.169	CbGbCtD
Flurbiprofen—UGT1A1—Mycophenolic acid—systemic scleroderma	0.065	0.146	CbGbCtD
Flurbiprofen—UGT1A9—Mycophenolate mofetil—systemic scleroderma	0.0444	0.1	CbGbCtD
Flurbiprofen—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.042	0.0946	CbGbCtD
Flurbiprofen—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0363	0.0818	CbGbCtD
Flurbiprofen—SLC22A6—Captopril—systemic scleroderma	0.0205	0.0462	CbGbCtD
Flurbiprofen—ALB—Captopril—systemic scleroderma	0.0175	0.0394	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—systemic scleroderma	0.0149	0.0335	CbGbCtD
Flurbiprofen—ALB—Mycophenolate mofetil—systemic scleroderma	0.0138	0.031	CbGbCtD
Flurbiprofen—CYP2C9—Leflunomide—systemic scleroderma	0.012	0.0271	CbGbCtD
Flurbiprofen—ALB—Prednisone—systemic scleroderma	0.011	0.0248	CbGbCtD
Flurbiprofen—SLC22A6—Methotrexate—systemic scleroderma	0.00648	0.0146	CbGbCtD
Flurbiprofen—CYP2C9—cardial valve—systemic scleroderma	0.00578	0.283	CbGeAlD
Flurbiprofen—ALB—Methotrexate—systemic scleroderma	0.00552	0.0124	CbGbCtD
Flurbiprofen—PTGS2—skeletal joint—systemic scleroderma	0.00181	0.0886	CbGeAlD
Flurbiprofen—UGT1A3—digestive system—systemic scleroderma	0.00122	0.0597	CbGeAlD
Flurbiprofen—UGT2B4—lung—systemic scleroderma	0.00106	0.052	CbGeAlD
Flurbiprofen—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000903	0.624	CbGdCrCtD
Flurbiprofen—UGT1A9—digestive system—systemic scleroderma	0.000868	0.0425	CbGeAlD
Flurbiprofen—PTGS1—artery—systemic scleroderma	0.000791	0.0388	CbGeAlD
Flurbiprofen—PTGS2—artery—systemic scleroderma	0.000756	0.0371	CbGeAlD
Flurbiprofen—UGT2B7—digestive system—systemic scleroderma	0.0007	0.0343	CbGeAlD
Flurbiprofen—PTGS1—endothelium—systemic scleroderma	0.000668	0.0328	CbGeAlD
Flurbiprofen—PTGS2—endothelium—systemic scleroderma	0.000639	0.0313	CbGeAlD
Flurbiprofen—PTGS1—blood vessel—systemic scleroderma	0.000616	0.0302	CbGeAlD
Flurbiprofen—UGT1A1—digestive system—systemic scleroderma	0.000595	0.0292	CbGeAlD
Flurbiprofen—PTGS2—blood vessel—systemic scleroderma	0.000589	0.0289	CbGeAlD
Flurbiprofen—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000545	0.376	CbGdCrCtD
Flurbiprofen—ABCC4—digestive system—systemic scleroderma	0.000388	0.019	CbGeAlD
Flurbiprofen—ABCC4—tendon—systemic scleroderma	0.000369	0.0181	CbGeAlD
Flurbiprofen—ABCC4—lung—systemic scleroderma	0.000324	0.0159	CbGeAlD
Flurbiprofen—PTGS1—connective tissue—systemic scleroderma	0.000316	0.0155	CbGeAlD
Flurbiprofen—PTGS2—connective tissue—systemic scleroderma	0.000302	0.0148	CbGeAlD
Flurbiprofen—PTGS1—smooth muscle tissue—systemic scleroderma	0.000289	0.0142	CbGeAlD
Flurbiprofen—PTGS1—skin of body—systemic scleroderma	0.000285	0.014	CbGeAlD
Flurbiprofen—PTGS2—smooth muscle tissue—systemic scleroderma	0.000276	0.0135	CbGeAlD
Flurbiprofen—PTGS2—skin of body—systemic scleroderma	0.000273	0.0134	CbGeAlD
Flurbiprofen—CYP2C9—digestive system—systemic scleroderma	0.00025	0.0123	CbGeAlD
Flurbiprofen—PTGS1—digestive system—systemic scleroderma	0.000228	0.0112	CbGeAlD
Flurbiprofen—PTGS2—digestive system—systemic scleroderma	0.000218	0.0107	CbGeAlD
Flurbiprofen—PTGS1—tendon—systemic scleroderma	0.000217	0.0106	CbGeAlD
Flurbiprofen—PTGS2—tendon—systemic scleroderma	0.000208	0.0102	CbGeAlD
Flurbiprofen—PTGS1—lung—systemic scleroderma	0.000191	0.00934	CbGeAlD
Flurbiprofen—PTGS2—lung—systemic scleroderma	0.000182	0.00893	CbGeAlD
Flurbiprofen—Shock—Lisinopril—systemic scleroderma	7.01e-05	0.000527	CcSEcCtD
Flurbiprofen—Angioedema—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.000525	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Lisinopril—systemic scleroderma	6.98e-05	0.000524	CcSEcCtD
Flurbiprofen—Dyspepsia—Mycophenolic acid—systemic scleroderma	6.96e-05	0.000523	CcSEcCtD
Flurbiprofen—Neutropenia—Prednisone—systemic scleroderma	6.96e-05	0.000523	CcSEcCtD
Flurbiprofen—Tachycardia—Lisinopril—systemic scleroderma	6.95e-05	0.000523	CcSEcCtD
Flurbiprofen—Abdominal pain—Azathioprine—systemic scleroderma	6.94e-05	0.000522	CcSEcCtD
Flurbiprofen—Body temperature increased—Azathioprine—systemic scleroderma	6.94e-05	0.000522	CcSEcCtD
Flurbiprofen—Malaise—Mycophenolate mofetil—systemic scleroderma	6.9e-05	0.000518	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Lisinopril—systemic scleroderma	6.89e-05	0.000518	CcSEcCtD
Flurbiprofen—Diarrhoea—Captopril—systemic scleroderma	6.88e-05	0.000517	CcSEcCtD
Flurbiprofen—Decreased appetite—Mycophenolic acid—systemic scleroderma	6.88e-05	0.000517	CcSEcCtD
Flurbiprofen—Vertigo—Mycophenolate mofetil—systemic scleroderma	6.87e-05	0.000516	CcSEcCtD
Flurbiprofen—Syncope—Mycophenolate mofetil—systemic scleroderma	6.86e-05	0.000515	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Prednisone—systemic scleroderma	6.85e-05	0.000515	CcSEcCtD
Flurbiprofen—Leukopenia—Mycophenolate mofetil—systemic scleroderma	6.85e-05	0.000514	CcSEcCtD
Flurbiprofen—Feeling abnormal—Leflunomide—systemic scleroderma	6.83e-05	0.000513	CcSEcCtD
Flurbiprofen—Mood swings—Methotrexate—systemic scleroderma	6.82e-05	0.000512	CcSEcCtD
Flurbiprofen—Nausea—Mometasone—systemic scleroderma	6.81e-05	0.000511	CcSEcCtD
Flurbiprofen—Anorexia—Lisinopril—systemic scleroderma	6.79e-05	0.00051	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Leflunomide—systemic scleroderma	6.78e-05	0.000509	CcSEcCtD
Flurbiprofen—Ataxia—Methotrexate—systemic scleroderma	6.77e-05	0.000508	CcSEcCtD
Flurbiprofen—Constipation—Mycophenolic acid—systemic scleroderma	6.77e-05	0.000508	CcSEcCtD
Flurbiprofen—Pain—Mycophenolic acid—systemic scleroderma	6.77e-05	0.000508	CcSEcCtD
Flurbiprofen—Palpitations—Mycophenolate mofetil—systemic scleroderma	6.76e-05	0.000508	CcSEcCtD
Flurbiprofen—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	6.72e-05	0.000505	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Prednisone—systemic scleroderma	6.71e-05	0.000504	CcSEcCtD
Flurbiprofen—Cough—Mycophenolate mofetil—systemic scleroderma	6.68e-05	0.000502	CcSEcCtD
Flurbiprofen—Hypotension—Lisinopril—systemic scleroderma	6.66e-05	0.0005	CcSEcCtD
Flurbiprofen—Dizziness—Captopril—systemic scleroderma	6.65e-05	0.0005	CcSEcCtD
Flurbiprofen—Convulsion—Mycophenolate mofetil—systemic scleroderma	6.63e-05	0.000498	CcSEcCtD
Flurbiprofen—Hypertension—Mycophenolate mofetil—systemic scleroderma	6.61e-05	0.000496	CcSEcCtD
Flurbiprofen—Urticaria—Leflunomide—systemic scleroderma	6.59e-05	0.000495	CcSEcCtD
Flurbiprofen—Abdominal pain—Leflunomide—systemic scleroderma	6.56e-05	0.000493	CcSEcCtD
Flurbiprofen—Body temperature increased—Leflunomide—systemic scleroderma	6.56e-05	0.000493	CcSEcCtD
Flurbiprofen—Acute coronary syndrome—Prednisone—systemic scleroderma	6.54e-05	0.000491	CcSEcCtD
Flurbiprofen—Feeling abnormal—Mycophenolic acid—systemic scleroderma	6.52e-05	0.00049	CcSEcCtD
Flurbiprofen—Myalgia—Mycophenolate mofetil—systemic scleroderma	6.51e-05	0.000489	CcSEcCtD
Flurbiprofen—Myocardial infarction—Prednisone—systemic scleroderma	6.5e-05	0.000489	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	6.49e-05	0.000488	CcSEcCtD
Flurbiprofen—Anxiety—Mycophenolate mofetil—systemic scleroderma	6.49e-05	0.000488	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	6.48e-05	0.000487	CcSEcCtD
Flurbiprofen—Hypersensitivity—Azathioprine—systemic scleroderma	6.47e-05	0.000486	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	6.47e-05	0.000486	CcSEcCtD
Flurbiprofen—Insomnia—Lisinopril—systemic scleroderma	6.45e-05	0.000484	CcSEcCtD
Flurbiprofen—Discomfort—Mycophenolate mofetil—systemic scleroderma	6.44e-05	0.000483	CcSEcCtD
Flurbiprofen—Paraesthesia—Lisinopril—systemic scleroderma	6.4e-05	0.000481	CcSEcCtD
Flurbiprofen—Vomiting—Captopril—systemic scleroderma	6.4e-05	0.000481	CcSEcCtD
Flurbiprofen—Dry mouth—Mycophenolate mofetil—systemic scleroderma	6.37e-05	0.000479	CcSEcCtD
Flurbiprofen—Dyspnoea—Lisinopril—systemic scleroderma	6.35e-05	0.000477	CcSEcCtD
Flurbiprofen—Rash—Captopril—systemic scleroderma	6.34e-05	0.000477	CcSEcCtD
Flurbiprofen—Dermatitis—Captopril—systemic scleroderma	6.34e-05	0.000476	CcSEcCtD
Flurbiprofen—Somnolence—Lisinopril—systemic scleroderma	6.34e-05	0.000476	CcSEcCtD
Flurbiprofen—Headache—Captopril—systemic scleroderma	6.3e-05	0.000474	CcSEcCtD
Flurbiprofen—Confusional state—Mycophenolate mofetil—systemic scleroderma	6.3e-05	0.000473	CcSEcCtD
Flurbiprofen—Dyspepsia—Lisinopril—systemic scleroderma	6.27e-05	0.000471	CcSEcCtD
Flurbiprofen—Abdominal pain—Mycophenolic acid—systemic scleroderma	6.25e-05	0.00047	CcSEcCtD
Flurbiprofen—Body temperature increased—Mycophenolic acid—systemic scleroderma	6.25e-05	0.00047	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.24e-05	0.000469	CcSEcCtD
Flurbiprofen—Oedema—Mycophenolate mofetil—systemic scleroderma	6.24e-05	0.000469	CcSEcCtD
Flurbiprofen—Asthma—Methotrexate—systemic scleroderma	6.22e-05	0.000467	CcSEcCtD
Flurbiprofen—Infection—Mycophenolate mofetil—systemic scleroderma	6.2e-05	0.000466	CcSEcCtD
Flurbiprofen—Decreased appetite—Lisinopril—systemic scleroderma	6.19e-05	0.000465	CcSEcCtD
Flurbiprofen—Eosinophilia—Methotrexate—systemic scleroderma	6.16e-05	0.000463	CcSEcCtD
Flurbiprofen—Shock—Mycophenolate mofetil—systemic scleroderma	6.14e-05	0.000462	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	6.11e-05	0.000459	CcSEcCtD
Flurbiprofen—Hypersensitivity—Leflunomide—systemic scleroderma	6.11e-05	0.000459	CcSEcCtD
Flurbiprofen—Pancreatitis—Methotrexate—systemic scleroderma	6.1e-05	0.000458	CcSEcCtD
Flurbiprofen—Pain—Lisinopril—systemic scleroderma	6.09e-05	0.000458	CcSEcCtD
Flurbiprofen—Constipation—Lisinopril—systemic scleroderma	6.09e-05	0.000458	CcSEcCtD
Flurbiprofen—Tachycardia—Mycophenolate mofetil—systemic scleroderma	6.09e-05	0.000458	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.04e-05	0.000453	CcSEcCtD
Flurbiprofen—Diarrhoea—Azathioprine—systemic scleroderma	6.01e-05	0.000451	CcSEcCtD
Flurbiprofen—Haemoglobin—Prednisone—systemic scleroderma	5.99e-05	0.00045	CcSEcCtD
Flurbiprofen—Nausea—Captopril—systemic scleroderma	5.98e-05	0.000449	CcSEcCtD
Flurbiprofen—Abdominal discomfort—Methotrexate—systemic scleroderma	5.96e-05	0.000448	CcSEcCtD
Flurbiprofen—Haemorrhage—Prednisone—systemic scleroderma	5.96e-05	0.000448	CcSEcCtD
Flurbiprofen—Anorexia—Mycophenolate mofetil—systemic scleroderma	5.95e-05	0.000447	CcSEcCtD
Flurbiprofen—Asthenia—Leflunomide—systemic scleroderma	5.95e-05	0.000447	CcSEcCtD
Flurbiprofen—Hallucination—Prednisone—systemic scleroderma	5.93e-05	0.000445	CcSEcCtD
Flurbiprofen—Pancytopenia—Methotrexate—systemic scleroderma	5.91e-05	0.000444	CcSEcCtD
Flurbiprofen—Feeling abnormal—Lisinopril—systemic scleroderma	5.87e-05	0.000441	CcSEcCtD
Flurbiprofen—Pruritus—Leflunomide—systemic scleroderma	5.87e-05	0.000441	CcSEcCtD
Flurbiprofen—Hypotension—Mycophenolate mofetil—systemic scleroderma	5.83e-05	0.000438	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Lisinopril—systemic scleroderma	5.83e-05	0.000438	CcSEcCtD
Flurbiprofen—Neutropenia—Methotrexate—systemic scleroderma	5.82e-05	0.000437	CcSEcCtD
Flurbiprofen—Dysuria—Methotrexate—systemic scleroderma	5.82e-05	0.000437	CcSEcCtD
Flurbiprofen—Dizziness—Azathioprine—systemic scleroderma	5.81e-05	0.000436	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Methotrexate—systemic scleroderma	5.73e-05	0.00043	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	5.69e-05	0.000427	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Methotrexate—systemic scleroderma	5.68e-05	0.000427	CcSEcCtD
Flurbiprofen—Asthenia—Mycophenolic acid—systemic scleroderma	5.68e-05	0.000426	CcSEcCtD
Flurbiprofen—Diarrhoea—Leflunomide—systemic scleroderma	5.67e-05	0.000426	CcSEcCtD
Flurbiprofen—Urticaria—Lisinopril—systemic scleroderma	5.66e-05	0.000425	CcSEcCtD
Flurbiprofen—Insomnia—Mycophenolate mofetil—systemic scleroderma	5.65e-05	0.000424	CcSEcCtD
Flurbiprofen—Body temperature increased—Lisinopril—systemic scleroderma	5.63e-05	0.000423	CcSEcCtD
Flurbiprofen—Abdominal pain—Lisinopril—systemic scleroderma	5.63e-05	0.000423	CcSEcCtD
Flurbiprofen—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	5.61e-05	0.000421	CcSEcCtD
Flurbiprofen—Pruritus—Mycophenolic acid—systemic scleroderma	5.6e-05	0.000421	CcSEcCtD
Flurbiprofen—Vomiting—Azathioprine—systemic scleroderma	5.58e-05	0.000419	CcSEcCtD
Flurbiprofen—Pneumonia—Methotrexate—systemic scleroderma	5.58e-05	0.000419	CcSEcCtD
Flurbiprofen—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	5.57e-05	0.000418	CcSEcCtD
Flurbiprofen—Somnolence—Mycophenolate mofetil—systemic scleroderma	5.55e-05	0.000417	CcSEcCtD
Flurbiprofen—Drowsiness—Methotrexate—systemic scleroderma	5.55e-05	0.000417	CcSEcCtD
Flurbiprofen—Rash—Azathioprine—systemic scleroderma	5.54e-05	0.000416	CcSEcCtD
Flurbiprofen—Dermatitis—Azathioprine—systemic scleroderma	5.53e-05	0.000416	CcSEcCtD
Flurbiprofen—Headache—Azathioprine—systemic scleroderma	5.5e-05	0.000413	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	5.5e-05	0.000413	CcSEcCtD
Flurbiprofen—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	5.5e-05	0.000413	CcSEcCtD
Flurbiprofen—Dizziness—Leflunomide—systemic scleroderma	5.48e-05	0.000412	CcSEcCtD
Flurbiprofen—Renal failure—Methotrexate—systemic scleroderma	5.45e-05	0.00041	CcSEcCtD
Flurbiprofen—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	5.43e-05	0.000408	CcSEcCtD
Flurbiprofen—Diarrhoea—Mycophenolic acid—systemic scleroderma	5.41e-05	0.000407	CcSEcCtD
Flurbiprofen—Stomatitis—Methotrexate—systemic scleroderma	5.41e-05	0.000406	CcSEcCtD
Flurbiprofen—Angiopathy—Prednisone—systemic scleroderma	5.4e-05	0.000406	CcSEcCtD
Flurbiprofen—Conjunctivitis—Methotrexate—systemic scleroderma	5.39e-05	0.000405	CcSEcCtD
Flurbiprofen—Constipation—Mycophenolate mofetil—systemic scleroderma	5.34e-05	0.000401	CcSEcCtD
Flurbiprofen—Pain—Mycophenolate mofetil—systemic scleroderma	5.34e-05	0.000401	CcSEcCtD
Flurbiprofen—Arrhythmia—Prednisone—systemic scleroderma	5.32e-05	0.0004	CcSEcCtD
Flurbiprofen—Sweating—Methotrexate—systemic scleroderma	5.32e-05	0.000399	CcSEcCtD
Flurbiprofen—Haematuria—Methotrexate—systemic scleroderma	5.29e-05	0.000397	CcSEcCtD
Flurbiprofen—Vomiting—Leflunomide—systemic scleroderma	5.27e-05	0.000396	CcSEcCtD
Flurbiprofen—Alopecia—Prednisone—systemic scleroderma	5.26e-05	0.000395	CcSEcCtD
Flurbiprofen—Hypersensitivity—Lisinopril—systemic scleroderma	5.25e-05	0.000394	CcSEcCtD
Flurbiprofen—Dizziness—Mycophenolic acid—systemic scleroderma	5.23e-05	0.000393	CcSEcCtD
Flurbiprofen—Epistaxis—Methotrexate—systemic scleroderma	5.23e-05	0.000393	CcSEcCtD
Flurbiprofen—Rash—Leflunomide—systemic scleroderma	5.23e-05	0.000393	CcSEcCtD
Flurbiprofen—Dermatitis—Leflunomide—systemic scleroderma	5.22e-05	0.000392	CcSEcCtD
Flurbiprofen—Nausea—Azathioprine—systemic scleroderma	5.22e-05	0.000392	CcSEcCtD
Flurbiprofen—Headache—Leflunomide—systemic scleroderma	5.2e-05	0.00039	CcSEcCtD
Flurbiprofen—Agranulocytosis—Methotrexate—systemic scleroderma	5.18e-05	0.000389	CcSEcCtD
Flurbiprofen—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.15e-05	0.000387	CcSEcCtD
Flurbiprofen—Asthenia—Lisinopril—systemic scleroderma	5.11e-05	0.000384	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	5.11e-05	0.000384	CcSEcCtD
Flurbiprofen—Pruritus—Lisinopril—systemic scleroderma	5.04e-05	0.000379	CcSEcCtD
Flurbiprofen—Vomiting—Mycophenolic acid—systemic scleroderma	5.03e-05	0.000378	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—systemic scleroderma	5e-05	0.000376	CcSEcCtD
Flurbiprofen—Rash—Mycophenolic acid—systemic scleroderma	4.99e-05	0.000375	CcSEcCtD
Flurbiprofen—Dermatitis—Mycophenolic acid—systemic scleroderma	4.98e-05	0.000374	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—systemic scleroderma	4.98e-05	0.000374	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—systemic scleroderma	4.98e-05	0.000374	CcSEcCtD
Flurbiprofen—Urticaria—Mycophenolate mofetil—systemic scleroderma	4.96e-05	0.000373	CcSEcCtD
Flurbiprofen—Headache—Mycophenolic acid—systemic scleroderma	4.96e-05	0.000372	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—systemic scleroderma	4.94e-05	0.000371	CcSEcCtD
Flurbiprofen—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	4.94e-05	0.000371	CcSEcCtD
Flurbiprofen—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	4.94e-05	0.000371	CcSEcCtD
Flurbiprofen—Nausea—Leflunomide—systemic scleroderma	4.93e-05	0.00037	CcSEcCtD
Flurbiprofen—Diarrhoea—Lisinopril—systemic scleroderma	4.88e-05	0.000366	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Prednisone—systemic scleroderma	4.81e-05	0.000361	CcSEcCtD
Flurbiprofen—Visual impairment—Methotrexate—systemic scleroderma	4.8e-05	0.00036	CcSEcCtD
Flurbiprofen—Anaemia—Prednisone—systemic scleroderma	4.79e-05	0.00036	CcSEcCtD
Flurbiprofen—Angioedema—Prednisone—systemic scleroderma	4.74e-05	0.000356	CcSEcCtD
Flurbiprofen—Dizziness—Lisinopril—systemic scleroderma	4.71e-05	0.000354	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—systemic scleroderma	4.71e-05	0.000354	CcSEcCtD
Flurbiprofen—Nausea—Mycophenolic acid—systemic scleroderma	4.7e-05	0.000353	CcSEcCtD
Flurbiprofen—Malaise—Prednisone—systemic scleroderma	4.68e-05	0.000351	CcSEcCtD
Flurbiprofen—Vertigo—Prednisone—systemic scleroderma	4.66e-05	0.00035	CcSEcCtD
Flurbiprofen—Syncope—Prednisone—systemic scleroderma	4.65e-05	0.000349	CcSEcCtD
Flurbiprofen—Tinnitus—Methotrexate—systemic scleroderma	4.64e-05	0.000349	CcSEcCtD
Flurbiprofen—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	4.6e-05	0.000346	CcSEcCtD
Flurbiprofen—Loss of consciousness—Prednisone—systemic scleroderma	4.56e-05	0.000342	CcSEcCtD
Flurbiprofen—Vomiting—Lisinopril—systemic scleroderma	4.53e-05	0.00034	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—systemic scleroderma	4.52e-05	0.000339	CcSEcCtD
Flurbiprofen—Rash—Lisinopril—systemic scleroderma	4.49e-05	0.000338	CcSEcCtD
Flurbiprofen—Convulsion—Prednisone—systemic scleroderma	4.49e-05	0.000338	CcSEcCtD
Flurbiprofen—Dermatitis—Lisinopril—systemic scleroderma	4.49e-05	0.000337	CcSEcCtD
Flurbiprofen—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.48e-05	0.000337	CcSEcCtD
Flurbiprofen—Hypertension—Prednisone—systemic scleroderma	4.48e-05	0.000336	CcSEcCtD
Flurbiprofen—Chills—Methotrexate—systemic scleroderma	4.47e-05	0.000336	CcSEcCtD
Flurbiprofen—Headache—Lisinopril—systemic scleroderma	4.46e-05	0.000335	CcSEcCtD
Flurbiprofen—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.42e-05	0.000332	CcSEcCtD
Flurbiprofen—Myalgia—Prednisone—systemic scleroderma	4.41e-05	0.000332	CcSEcCtD
Flurbiprofen—Anxiety—Prednisone—systemic scleroderma	4.4e-05	0.000331	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—systemic scleroderma	4.4e-05	0.000331	CcSEcCtD
Flurbiprofen—Discomfort—Prednisone—systemic scleroderma	4.36e-05	0.000328	CcSEcCtD
Flurbiprofen—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.27e-05	0.000321	CcSEcCtD
Flurbiprofen—Nausea—Lisinopril—systemic scleroderma	4.23e-05	0.000318	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Prednisone—systemic scleroderma	4.23e-05	0.000318	CcSEcCtD
Flurbiprofen—Oedema—Prednisone—systemic scleroderma	4.23e-05	0.000318	CcSEcCtD
Flurbiprofen—Infection—Prednisone—systemic scleroderma	4.2e-05	0.000316	CcSEcCtD
Flurbiprofen—Shock—Prednisone—systemic scleroderma	4.16e-05	0.000313	CcSEcCtD
Flurbiprofen—Tachycardia—Prednisone—systemic scleroderma	4.13e-05	0.00031	CcSEcCtD
Flurbiprofen—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.13e-05	0.00031	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Prednisone—systemic scleroderma	4.09e-05	0.000307	CcSEcCtD
Flurbiprofen—Anorexia—Prednisone—systemic scleroderma	4.03e-05	0.000303	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Methotrexate—systemic scleroderma	4.02e-05	0.000302	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—systemic scleroderma	4.01e-05	0.000301	CcSEcCtD
Flurbiprofen—Vomiting—Mycophenolate mofetil—systemic scleroderma	3.97e-05	0.000298	CcSEcCtD
Flurbiprofen—Rash—Mycophenolate mofetil—systemic scleroderma	3.94e-05	0.000296	CcSEcCtD
Flurbiprofen—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.93e-05	0.000295	CcSEcCtD
Flurbiprofen—Headache—Mycophenolate mofetil—systemic scleroderma	3.91e-05	0.000294	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—systemic scleroderma	3.91e-05	0.000294	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—systemic scleroderma	3.89e-05	0.000293	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—systemic scleroderma	3.88e-05	0.000291	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Prednisone—systemic scleroderma	3.86e-05	0.00029	CcSEcCtD
Flurbiprofen—Insomnia—Prednisone—systemic scleroderma	3.83e-05	0.000288	CcSEcCtD
Flurbiprofen—Paraesthesia—Prednisone—systemic scleroderma	3.8e-05	0.000286	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—systemic scleroderma	3.78e-05	0.000284	CcSEcCtD
Flurbiprofen—Convulsion—Methotrexate—systemic scleroderma	3.76e-05	0.000282	CcSEcCtD
Flurbiprofen—Dyspepsia—Prednisone—systemic scleroderma	3.73e-05	0.00028	CcSEcCtD
Flurbiprofen—Nausea—Mycophenolate mofetil—systemic scleroderma	3.71e-05	0.000279	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—systemic scleroderma	3.69e-05	0.000277	CcSEcCtD
Flurbiprofen—Decreased appetite—Prednisone—systemic scleroderma	3.68e-05	0.000276	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—systemic scleroderma	3.65e-05	0.000274	CcSEcCtD
Flurbiprofen—Constipation—Prednisone—systemic scleroderma	3.62e-05	0.000272	CcSEcCtD
Flurbiprofen—Confusional state—Methotrexate—systemic scleroderma	3.57e-05	0.000268	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—systemic scleroderma	3.54e-05	0.000266	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—systemic scleroderma	3.51e-05	0.000264	CcSEcCtD
Flurbiprofen—Feeling abnormal—Prednisone—systemic scleroderma	3.49e-05	0.000262	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—systemic scleroderma	3.46e-05	0.00026	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Prednisone—systemic scleroderma	3.46e-05	0.00026	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—systemic scleroderma	3.42e-05	0.000257	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—systemic scleroderma	3.37e-05	0.000253	CcSEcCtD
Flurbiprofen—Urticaria—Prednisone—systemic scleroderma	3.36e-05	0.000253	CcSEcCtD
Flurbiprofen—Abdominal pain—Prednisone—systemic scleroderma	3.35e-05	0.000251	CcSEcCtD
Flurbiprofen—Body temperature increased—Prednisone—systemic scleroderma	3.35e-05	0.000251	CcSEcCtD
Flurbiprofen—Hypotension—Methotrexate—systemic scleroderma	3.31e-05	0.000248	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.22e-05	0.000242	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—systemic scleroderma	3.2e-05	0.00024	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—systemic scleroderma	3.18e-05	0.000239	CcSEcCtD
Flurbiprofen—Dyspnoea—Methotrexate—systemic scleroderma	3.15e-05	0.000237	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—systemic scleroderma	3.14e-05	0.000236	CcSEcCtD
Flurbiprofen—Hypersensitivity—Prednisone—systemic scleroderma	3.12e-05	0.000234	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—systemic scleroderma	3.11e-05	0.000234	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—systemic scleroderma	3.07e-05	0.000231	CcSEcCtD
Flurbiprofen—Asthenia—Prednisone—systemic scleroderma	3.04e-05	0.000228	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—systemic scleroderma	3.02e-05	0.000227	CcSEcCtD
Flurbiprofen—Pruritus—Prednisone—systemic scleroderma	2.99e-05	0.000225	CcSEcCtD
Flurbiprofen—Feeling abnormal—Methotrexate—systemic scleroderma	2.91e-05	0.000219	CcSEcCtD
Flurbiprofen—Diarrhoea—Prednisone—systemic scleroderma	2.9e-05	0.000218	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—systemic scleroderma	2.89e-05	0.000217	CcSEcCtD
Flurbiprofen—Urticaria—Methotrexate—systemic scleroderma	2.81e-05	0.000211	CcSEcCtD
Flurbiprofen—Dizziness—Prednisone—systemic scleroderma	2.8e-05	0.00021	CcSEcCtD
Flurbiprofen—Abdominal pain—Methotrexate—systemic scleroderma	2.8e-05	0.00021	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—systemic scleroderma	2.8e-05	0.00021	CcSEcCtD
Flurbiprofen—Vomiting—Prednisone—systemic scleroderma	2.69e-05	0.000202	CcSEcCtD
Flurbiprofen—Rash—Prednisone—systemic scleroderma	2.67e-05	0.0002	CcSEcCtD
Flurbiprofen—Dermatitis—Prednisone—systemic scleroderma	2.67e-05	0.0002	CcSEcCtD
Flurbiprofen—Headache—Prednisone—systemic scleroderma	2.65e-05	0.000199	CcSEcCtD
Flurbiprofen—Hypersensitivity—Methotrexate—systemic scleroderma	2.61e-05	0.000196	CcSEcCtD
Flurbiprofen—Asthenia—Methotrexate—systemic scleroderma	2.54e-05	0.000191	CcSEcCtD
Flurbiprofen—Nausea—Prednisone—systemic scleroderma	2.51e-05	0.000189	CcSEcCtD
Flurbiprofen—Pruritus—Methotrexate—systemic scleroderma	2.5e-05	0.000188	CcSEcCtD
Flurbiprofen—Diarrhoea—Methotrexate—systemic scleroderma	2.42e-05	0.000182	CcSEcCtD
Flurbiprofen—Dizziness—Methotrexate—systemic scleroderma	2.34e-05	0.000176	CcSEcCtD
Flurbiprofen—Vomiting—Methotrexate—systemic scleroderma	2.25e-05	0.000169	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—systemic scleroderma	2.23e-05	0.000168	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—systemic scleroderma	2.23e-05	0.000167	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—systemic scleroderma	2.22e-05	0.000166	CcSEcCtD
Flurbiprofen—Nausea—Methotrexate—systemic scleroderma	2.1e-05	0.000158	CcSEcCtD
